FridayOL

Lumos Pharma Secures Landmark $487 Million US Distribution Agreement, Propelling Biotech Growth

Stockhead

Australian biotech company Lumos Diagnostics (ASX: LMD) has announced a monumental deal that's sending ripples of excitement through the industry. The company has inked a six-year exclusive distribution agreement with PHASE Scientific, a leading US-b ...Read more